-
Story / -
Story /Researchers focus on reversing the scarring that’s common to liver diseases.
-
Story /Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.
-
Story /A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
-
Story /Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
-
Story /A diminutive protein prompts a closer look at DNA dark matter.
-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Story /Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
-
Story /Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.
-
Story /University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
Pagination
- ‹ Previous page
- 1
- …
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- …
- 278
- › Next page